Association of No-Cost Genetic Testing Program Implementation and Patient Characteristics With Access to Genetic Testing for Inherited Retinal Degenerations.

ABSTRACT:

Importance

The benefits of no-cost genetic testing initiatives have not been characterized. The no-cost My Retina Tracker Genetic Testing Study (MRT-GTS) research registry for inherited retinal degenerations (IRDs) was launched in 2017 in the US.

Objective

To investigate the associations of MRT-GTS implementation and patient characteristics with access to genetic testing for IRDs.

Design, setting, and participants

In a cross-sectional design, analysis of new patients evaluated 12 months before (July 1, 2016, to June 13, 2017) and 12 months after (June 14, 2017, to June 30, 2018) MRT-GTS implementation at a single academic referral eye center was conducted. Participants included 369 patients with IRD. Data analysis was conducted from February to June 2020.

Main outc

SUBMITTER: Zhao PY 

PROVIDER: S-EPMC7934082 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature